Immunocore Statistics
NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
26.41-0.22 (-0.83%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Immunocore by the numbers
Immunocore has a market capitalization of $1.36 billion based on 51.68M shares outstanding. With trailing EPS of $-0.64, Immunocore is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 13.0% below its 50-day average and 16.1% below its 200-day average.
Average daily trading volume is 450.88K shares, or about $11.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IMCR valuation vs. peer median
| Metric | IMCR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.36B | $1.43B | -5% |
| Avg. volume | 450.88K | 1.79M | -75% |
Peer median across 8 companies: MESO, WWB, ALVO, NVAX, RXRX, TSHA, VIR, VOR.
Valuation
- Market cap
- $1.36B
- Price / sales (latest FY)
- 3.41
- EPS (TTM)
- $-0.64
- Shares outstanding
- 51.68M
Price and trading
- Previous close
- 26.63
- Open
- 26.37
- Day range
- 25.61 – 26.77
- 52-week range
- 25.61 – 40.72
- 52-week change
- -32.88%
- Beta
- —
- Volume
- 546.18K
- Average volume
- 450.88K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 1.36B
- Forward Pe
- -41.10
- Eps
- -0.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 40.72
- Week52 Low
- 25.61
- Avg Volume
- 450.88K
- Shares Outstanding
- 51.68M
- Ma50
- 30.37
- Ma200
- 31.47
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -35.13%
- Pct From52w Low
- 3.11%